UPenn Perelman School of Medicine: Immunotherapy May Boost KRAS-Targeted Therapy in Pancreatic Cancer
March 15, 2025
March 15, 2025
PHILADELPHIA, Pennsylvania, March 15 -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Preclinical study offers foundation for a combination strategy in future clinical trials
PHILADELPHIA - Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreat . . .
* * *
Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer
Preclinical study offers foundation for a combination strategy in future clinical trials
PHILADELPHIA - Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreat . . .